NIH launches trial of Rigel drug for severe COVID-19
Go back to NIH launches trial of Rigel drug for severe COVID-19| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.67 +0.17 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.50 | 52 Week High | $4.38 | |||
| Open | $48.04 | 52 Week Low | $1.88 | |||
| Day High | $48.87 | P/E | N/A | |||
| Day Low | $47.77 | EPS | $-1.12 | |||
| Volume | 104,968 | |||||
